ARTICLE | Company News
LCT, Otsuka Pharmaceutical deal
October 24, 2011 7:00 AM UTC
Living Cell and Otsuka will establish a 50/50 JV, to be named Diatranz Otsuka Ltd., to develop and commercialize Living Cell's DiabeCell worldwide, except for China. Otsuka will contribute A$25 millio...